Doxycycline Hyclate* (Doxycycline Hyclate) — Medicare Part D spending
Multiple manufacturers (32) · Rank #350 by total Part D spend · CMS data year 2023
Medicare Part D spent $117,340,524 on Doxycycline Hyclate* (Doxycycline Hyclate) in 2023, the #350 drug by total Part D spending out of 3,598 drugs. That worked out to about $0.80 per dosage unit, $20 per claim and $28 per beneficiary, across 5,913,074 claims for 4,121,486 beneficiaries. Average spending per dosage unit fell -13.5% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Doxycycline Hyclate* (Doxycycline Hyclate) spending at a glance (2023)
| Metric | Doxycycline Hyclate* (Doxycycline Hyclate) |
|---|---|
| Total Part D spending (2023) | $117,340,524 |
| Total spending (2022) | $121,392,076 |
| Year-over-year change in total spending | -3.3% |
| Average spending per dosage unit (2023) | $0.80 |
| Change in spend per dosage unit (YoY) | -13.5% |
| Avg annual change per dosage unit (2019-2023 CAGR) | -8.4% |
| Average spending per claim (2023) | $20 |
| Average spending per beneficiary (2023) | $28 |
| Total claims (2023) | 5,913,074 |
| Beneficiaries (2023) | 4,121,486 |
| Total dosage units (2023) | 151,834,849 |
| Manufacturer(s) | Multiple manufacturers (32) |
| National rank by total spend (of 3,598 drugs) | #350 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $121,392,076 | $117,340,524 | -3.3% |
| Avg spend per dosage unit | $0.92 | $0.80 | -13.5% |
| Avg spend per claim | $24 | $20 | — |
| Avg spend per beneficiary | $34 | $28 | — |
| Total claims | 5,139,744 | 5,913,074 | — |
| Beneficiaries | 3,566,574 | 4,121,486 | — |
How Doxycycline Hyclate* compares with nearby drugs
Drugs with total Part D spending closest to Doxycycline Hyclate* (Doxycycline Hyclate):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Doxycycline Hyclate* (Doxycycline Hyclate) (this drug, #350) | $117,340,524 | $0.80 | -13.5% |
| Trulance (Plecanatide) (#345) | $119,272,260 | $18.72 | +7.4% |
| Idhifa (Enasidenib Mesylate) (#346) | $118,905,343 | $1,086.10 | +7.1% |
| Losartan-Hydrochlorothiazide (Losartan/Hydrochlorothiazide) (#347) | $118,183,005 | $0.29 | +10.8% |
| Vyndaqel (Tafamidis Meglumine) (#348) | $118,169,381 | $181.48 | +5.3% |
| Vyzulta (Latanoprostene Bunod) (#349) | $117,369,728 | $100.85 | +7.3% |
Frequently asked questions
How much does Medicare Part D spend on Doxycycline Hyclate*?
Medicare Part D spent $117,340,524 on Doxycycline Hyclate* (Doxycycline Hyclate) in 2023 (the latest CMS data year), across 5,913,074 claims for 4,121,486 beneficiaries. That ranks #350 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Doxycycline Hyclate*?
In 2023, the weighted average Medicare Part D spending per dosage unit for Doxycycline Hyclate* (Doxycycline Hyclate) was $0.80. Compared with 2022 it fell -13.5%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Doxycycline Hyclate*?
CMS attributes Doxycycline Hyclate* (Doxycycline Hyclate) to Multiple manufacturers (32) in the 2023 Part D spending file. Average spending per claim was $20 and per beneficiary $28.
Is the Doxycycline Hyclate* figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20